scholarly journals Comparative effect of body-mass index on outcome with targeted therapy and immunotherapy in patients with metastatic renal cell carcinoma (mRCC)

2018 ◽  
Vol 29 ◽  
pp. viii318 ◽  
Author(s):  
N. Dizman ◽  
P. Bergerot ◽  
C.D. Bergerot ◽  
E.J. Philip ◽  
M.M. Salgia ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Renal Cell Carcinoma ◽  
Targeted Therapy ◽  
Cell Carcinoma ◽  
Body Mass ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Comparative Effect

scholarly journals Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma

Kidney Cancer ◽  
2019 ◽  
Vol 3 (1) ◽  
pp. 63-70 ◽  
Author(s):  
Paulo Gustavo Bergerot ◽  
Cristiane Decat Bergerot ◽  
Errol J. Philip ◽  
Luis Meza ◽  
Nazli Dizman ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Renal Cell Carcinoma ◽  
Targeted Therapy ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Body Mass ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell

Do body mass index (BMI) and body surface area (BSA) influence the outcome of metastatic renal cell carcinoma?

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e15162-e15162
Author(s):  
S. Waalkes ◽  
V. Gruenwald ◽  
C. Seidel ◽  
H. Eggers ◽  
G. Wegener ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Surface Area ◽  
Body Surface Area ◽  
Body Mass ◽  
Metastatic Renal Cell Carcinoma ◽  
Body Surface ◽  
Renal Cell
Sign in / Sign up

Export Citation Format

Share Document